ANI PHARMACEUTICALS, INC Impairment of Intangible Assets, Finite-lived
ANI PHARMACEUTICALS, INC (ANIP) reported Impairment of Intangible Assets, Finite-lived of $800.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-27.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ImpairmentOfIntangibleAssetsFinitelived · last filed 2026-02-27
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for the quarter ending 2024-12-31 was $3.60M.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for the quarter ending 2024-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for the quarter ending 2024-06-30 was $0.00.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for the quarter ending 2024-03-31 was $0.00.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for fiscal 2025 was $800.00K, a 77.78% decline from fiscal 2024.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for fiscal 2024 was $3.60M.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for fiscal 2023 was $0.00, a 100.00% decline from fiscal 2022.
- ANI PHARMACEUTICALS, INC impairment of intangible assets, finite-lived for fiscal 2022 was $100.00K, a 95.79% decline from fiscal 2021.
| Period end | Impairment of Intangible Assets, Finite-lived 3 month | Impairment of Intangible Assets, Finite-lived 6 month | Impairment of Intangible Assets, Finite-lived 9 month | Impairment of Intangible Assets, Finite-lived 12 month | Impairment of Intangible Assets, Finite-lived 12 month as first filed |
|---|---|---|---|---|---|
| 2025-12-31 | $800.00K 10-K · filed 2026-02-27 | ||||
| 2024-12-31 | $3.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $3.60M derived: sum of 2 quarters · filed 2026-02-27 | $3.60M derived: sum of 3 quarters · filed 2026-02-27 | $3.60M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $0.00 10-Q · filed 2024-05-10 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $0.00 derived: sum of 2 quarters · filed 2026-02-27 | $0.00 derived: sum of 3 quarters · filed 2026-02-27 | $0.00 10-K · filed 2026-02-27 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-08 | $0.00 derived: sum of 2 quarters · filed 2024-11-08 | $0.00 10-Q · filed 2024-11-08 | -$12.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | -$12.00K derived: sum of 3 quarters · filed 2025-02-28 | -$12.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-10 | -$12.00K derived: sum of 2 quarters · filed 2025-02-28 | -$12.00K derived: sum of 3 quarters · filed 2025-02-28 | $100.00K derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | -$12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | -$12.00K derived: sum of 2 quarters · filed 2025-02-28 | $100.00K derived: sum of 3 quarters · filed 2025-02-28 | $100.00K 10-K · filed 2025-02-28 | $112.00K 10-K · filed 2023-03-09 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $112.00K derived: sum of 2 quarters · filed 2023-11-08 | $112.00K 10-Q · filed 2023-11-08 | $2.49M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-06-30 | $112.00K 10-Q · filed 2023-08-09 | $112.00K 10-Q · filed 2023-08-09 | $2.49M derived: sum of 3 quarters · filed 2024-02-29 | $2.49M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-08 | $2.37M derived: sum of 2 quarters · filed 2024-02-29 | $2.37M derived: sum of 3 quarters · filed 2024-02-29 | $2.37M derived: sum of 4 quarters · filed 2024-02-29 | |
| 2021-12-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $2.37M derived: sum of 2 quarters · filed 2024-02-29 | $2.37M derived: sum of 3 quarters · filed 2024-02-29 | $2.37M 10-K · filed 2024-02-29 | |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-09 | $0.00 derived: sum of 2 quarters · filed 2022-11-09 | $0.00 10-Q · filed 2022-11-09 | $446.00K derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-08 | $0.00 10-Q · filed 2022-08-08 | $446.00K derived: sum of 3 quarters · filed 2023-03-09 | $446.00K derived: sum of 4 quarters · filed 2023-03-09 | |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-10 | $446.00K derived: sum of 2 quarters · filed 2023-03-09 | $446.00K derived: sum of 3 quarters · filed 2023-03-09 | $446.00K derived: sum of 4 quarters · filed 2023-03-09 | |
| 2020-12-31 | $446.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-09 | $446.00K derived: sum of 2 quarters · filed 2023-03-09 | $446.00K derived: sum of 3 quarters · filed 2023-03-09 | $446.00K 10-K · filed 2023-03-09 | |
| 2020-09-30 | $0.00 10-Q · filed 2021-11-01 | $0.00 derived: sum of 2 quarters · filed 2021-11-01 | $0.00 10-Q · filed 2021-11-01 | $75.00K derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2021-08-06 | $75.00K derived: sum of 3 quarters · filed 2022-03-15 | $75.00K derived: sum of 4 quarters · filed 2022-03-15 | |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | $75.00K derived: sum of 2 quarters · filed 2022-03-15 | $75.00K derived: sum of 3 quarters · filed 2022-03-15 | $75.00K derived: sum of 4 quarters · filed 2022-03-15 | |
| 2019-12-31 | $75.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $75.00K derived: sum of 2 quarters · filed 2022-03-15 | $75.00K derived: sum of 3 quarters · filed 2022-03-15 | $75.00K 10-K · filed 2022-03-15 | |
| 2019-09-30 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 2 quarters · filed 2020-11-05 | $0.00 10-Q · filed 2020-11-05 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-08-06 | $0.00 10-Q · filed 2020-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 derived: sum of 4 quarters · filed 2021-03-11 | |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-11 | $0.00 derived: sum of 2 quarters · filed 2021-03-11 | $0.00 derived: sum of 3 quarters · filed 2021-03-11 | $0.00 10-K · filed 2021-03-11 | |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | ||
| 2018-06-30 | $0.00 10-Q · filed 2019-08-07 | $0.00 10-Q · filed 2019-08-07 | |||
| 2017-12-31 | $903.00K 10-K · filed 2020-02-27 | ||||
| 2016-12-31 | $6.68M 10-K · filed 2019-02-27 | ||||
| 2015-12-31 | $0.00 10-K · filed 2018-02-27 | ||||
| 2014-12-31 | $0.00 10-K · filed 2017-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |